Health & Environmental Research Online (HERO)


Print Feedback Export to File
4100704 
Journal Article 
Down-regulation of Sphk2 suppresses bladder cancer progression 
Sun, E; Zhang, W; Wang, L; Wang, A; Ma, C; Lei, M; Zhou, X; Sun, Y; Lu, B; Liu, L; Han, R 
2016 
1 
Tumor Biology
ISSN: 1010-4283
EISSN: 1423-0380 
37 
1 
473-478 
English 
26224479 
WOS:000374576200051 
has retraction 4098513 Retraction Note to multiple articles in Tumor Biology
Bladder cancer is the second most common urological malignancy around the world and is by far the most frequent urological malignancy in China. The abnormal expression of sphingosine kinase 2 (SphK2) is associated with tumor progression and a poor patient survival rate, however, the effect of SphK2 on the bladder cancer cells remains unclear. The aim of the paper was to study the expression of SphK2 in bladder cancer and the role of SphK2 on the cell proliferation, metastasis, and apoptosis in bladder cancer in vitro. Our results showed that SphK2 is up-regulated in bladder cancer tissues compared with the corresponding adjacent non-neoplastic tissues, and the expression level of SphK2 was significantly higher in human bladder cancer cells in comparison with normal bladder epithelial cells. Silencing of SphK2 could inhibit the proliferation ability of T24 cells in vitro. In addition, SphK2 knockdown could induce a significant increase in the number of apoptotic cells. Furthermore, the transwell assay also showed significant cell migration inhibition in SphK2 siRNA transfectant compared with cell lines transfected with NC. Thus, this study suggested that SphK2 inhibition may provide a promising treatment for bladder cancer patients.